Marshall Wace’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.5M | Sell |
21,902
-17,676
| -45% | -$8.44M | 0.01% | 909 |
|
|
2025
Q4 | $23M | Buy |
39,578
+38,878
| +5,554% | +$19.9M | 0.02% | 586 |
|
|
2025
Q3 | $321K | Sell |
700
-54,419
| -99% | -$20.3M | ﹤0.01% | 2400 |
|
|
2025
Q2 | $16.7M | Buy |
55,119
+52,319
| +1,869% | +$15.6M | 0.02% | 656 |
|
|
2025
Q1 | $927K | Sell |
2,800
-14,694
| -84% | -$4.83M | ﹤0.01% | 1818 |
|
|
2024
Q4 | $5.4M | Sell |
17,494
-62,907
| -78% | -$17.7M | 0.01% | 1021 |
|
|
2024
Q3 | $17.1M | Buy |
80,401
+78,701
| +4,629% | +$20.1M | 0.02% | 566 |
|
|
2024
Q2 | $476K | Buy |
+1,700
| New | +$405K | ﹤0.01% | 1981 |
|
|
2024
Q1 | – | Sell |
-33,071
| Closed | -$7.65M | – | 2702 |
|
|
2023
Q4 | $7.65M | Sell |
33,071
-362,327
| -92% | -$63.4M | 0.01% | 763 |
|
|
2023
Q3 | $57.7M | Sell |
395,398
-65,246
| -14% | -$12.3M | 0.12% | 176 |
|
|
2023
Q2 | $106M | Sell |
460,644
-81,120
| -15% | -$22M | 0.23% | 94 |
|
|
2023
Q1 | $131M | Buy |
+541,764
| New | +$148M | 0.32% | 73 |
|
|
2022
Q1 | – | Sell |
-608
| Closed | -$52K | – | 3786 |
|
|
2021
Q4 | $52K | Buy |
+608
| New | +$50K | ﹤0.01% | 3549 |
|
|
2021
Q3 | – | Sell |
-98,180
| Closed | -$9.56M | – | 3304 |
|
|
2021
Q2 | $9.56M | Buy |
+98,180
| New | +$11.6M | 0.05% | 509 |
|
|
2020
Q1 | – | Sell |
-1,350
| Closed | -$123K | – | 1887 |
|
|
2019
Q4 | $123K | Sell |
1,350
-686
| -34% | -$66.5K | ﹤0.01% | 1423 |
|
|
2019
Q3 | $175K | Buy |
+2,036
| New | +$191K | ﹤0.01% | 1306 |
|
|
2019
Q2 | – | Sell |
-20,462
| Closed | -$2.56M | – | 1636 |
|
|
2019
Q1 | $2.56M | Buy |
+20,462
| New | +$2.54M | 0.02% | 664 |
|
|
2018
Q4 | – | Sell |
-19,808
| Closed | -$4.24M | – | 1720 |
|
|
2018
Q3 | $4.24M | Buy |
+19,808
| New | +$4.97M | 0.04% | 493 |
|
Other funds holding MDGL
BBA
RI
ACA
PC
VPM
VCM
